{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:59:09Z","timestamp":1793642349637,"version":"4.5.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2025J08052"],"award-info":[{"award-number":["2025J08052"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005270","name":"Fujian Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["2024Y9080"],"award-info":[{"award-number":["2024Y9080"]}],"id":[{"id":"10.13039\/501100005270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,3,10]]},"DOI":"10.1038\/s41388-026-03688-x","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T14:38:56Z","timestamp":1770302336000},"page":"745-756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Interstitial cystitis-related gene CCDC8 accelerates tumorigenesis by participating in CUL7-mediated degradation of P53 in bladder cancer"],"prefix":"10.1038","volume":"45","author":[{"given":"Jiawen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qidong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liefu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7088-1373","authenticated-orcid":false,"given":"Jinfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"3688_CR1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s11912-025-01657-3","volume":"27","author":"S Popli","year":"2025","unstructured":"Popli S, Durant AM, Tyson M, Singh P. Current state of bladder preservation in high grade non-muscle invasive bladder cancer and localized muscle invasive bladder cancer. Curr Oncol Rep. 2025;27:761\u201373. https:\/\/doi.org\/10.1007\/s11912-025-01657-3.","journal-title":"Curr Oncol Rep"},{"key":"3688_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/nau.22283","volume":"32","author":"J Keller","year":"2013","unstructured":"Keller J, Chiou H-Y, Lin H-C. Increased risk of bladder cancer following diagnosis with bladder pain syndrome\/interstitial cystitis. Neurourol Urodyn. 2013;32:58\u201362. https:\/\/doi.org\/10.1002\/nau.22283.","journal-title":"Neurourol Urodyn"},{"key":"3688_CR3","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.6004\/jnccn.2013.0172","volume":"11","author":"V Pokuri","year":"2013","unstructured":"Pokuri V, Sule N, Soofi Y, Xu B, Guru K, George S. A case of unusual mast cell response with interstitial cystitis-like symptoms to neoadjuvant chemotherapy for muscle-invasive transitional cell carcinoma of the bladder. J Natl Compr Cancer Netw. 2013;11:1459\u201363. https:\/\/doi.org\/10.6004\/jnccn.2013.0172.","journal-title":"J Natl Compr Cancer Netw"},{"key":"3688_CR4","doi-asserted-by":"publisher","unstructured":"Huck C, Achard V, Efstathiou J, Damme JV, Zlotta AR, Xylinas E, et al. Radiation therapy in the management of muscle-invasive bladder cancer with carcinoma in situ: still a no go? Eur Urol Oncol. 2025. https:\/\/doi.org\/10.1016\/j.euo.2025.05.028.","DOI":"10.1016\/j.euo.2025.05.028"},{"key":"3688_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104862","volume":"215","author":"M Ferro","year":"2025","unstructured":"Ferro M, Crocetto F, Jannello LMI, Contieri R, Falagario UG, Veccia A, et al. Emerging biomarkers in bladder cancer: translating molecular advances into precision oncology. Crit Rev Oncol Hematol. 2025;215:104862. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104862.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3688_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05864-7","volume":"23","author":"X Yang","year":"2025","unstructured":"Yang X, Wu X, Hao X, Li T, Guo H, Yang R. Unleashing the therapeutic potential of tumor-draining lymph nodes: spotlight on bladder cancer. J Transl Med. 2025;23:489. https:\/\/doi.org\/10.1186\/s12967-024-05864-7.","journal-title":"J Transl Med"},{"key":"3688_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216225","volume":"565","author":"Z Liu","year":"2023","unstructured":"Liu Z, Yan W, Liu S, Liu Z, Xu P, Fang W. Regulatory network and targeted interventions for CCDC family in tumor pathogenesis. Cancer Lett. 2023;565:216225. https:\/\/doi.org\/10.1016\/j.canlet.2023.216225.","journal-title":"Cancer Lett"},{"key":"3688_CR8","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1007\/s43032-021-00595-2","volume":"28","author":"PP Priyanka","year":"2021","unstructured":"Priyanka PP, Yenugu S. Coiled-coil domain-containing (CCDC) proteins: functional roles in general and male reproductive physiology. Reprod Sci. 2021;28:2725\u201334. https:\/\/doi.org\/10.1007\/s43032-021-00595-2.","journal-title":"Reprod Sci"},{"key":"3688_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/15548627.2023.2259214","volume":"20","author":"X Jin","year":"2024","unstructured":"Jin X, You L, Qiao J, Han W, Pan H. Autophagy in colitis-associated colon cancer: exploring its potential role in reducing initiation and preventing IBD-Related CAC development. Autophagy. 2024;20:242\u201358. https:\/\/doi.org\/10.1080\/15548627.2023.2259214.","journal-title":"Autophagy"},{"key":"3688_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156577","volume":"140","author":"Y-J Niu","year":"2025","unstructured":"Niu Y-J, Ai X, Lin X-T, Xu W-M, Lao S-Y, Tian Z-C, et al. Baicalein inhibits hepatitis B virus through the coiled coil domain containing protein 88A (CCDC88A)-dependent autophagy pathway. Phytomedicine. 2025;140:156577. https:\/\/doi.org\/10.1016\/j.phymed.2025.156577.","journal-title":"Phytomedicine"},{"key":"3688_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/15548627.2022.2080957","volume":"19","author":"P Hou","year":"2023","unstructured":"Hou P, Tian T, Jia P, Lin Y, Li Z, Wang Y, et al. The regulation of NLRP3 inflammasome activation by CCDC50-mediated autophagy. Autophagy. 2023;19:365\u20136. https:\/\/doi.org\/10.1080\/15548627.2022.2080957.","journal-title":"Autophagy"},{"key":"3688_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.33549\/physiolres.934547","volume":"70","author":"H-H Wang","year":"2021","unstructured":"Wang H-H, Luo W-Y, Lin M, Li X-J, Xiang G-D, D Triganti S. Plasma asprosin, CCDC80 and ANGPTL4 levels are associated with metabolic and cardiovascular risk in patients with inflammatory bowel disease. Physiol Res. 2021;70:203\u201311. https:\/\/doi.org\/10.33549\/physiolres.934547.","journal-title":"Physiol Res"},{"key":"3688_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.gdata.2014.10.009","volume":"2","author":"SJ Walker","year":"2014","unstructured":"Walker SJ, Colaco M, Koslov DS, Keys T, Evans RJ, Badlani GH, et al. Transcriptome analysis of bladder biopsy from interstitial cystitis\/bladder pain syndrome patients. Genom Data. 2014;2:366\u20138. https:\/\/doi.org\/10.1016\/j.gdata.2014.10.009.","journal-title":"Genom Data"},{"key":"3688_CR14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.juro.2014.05.047","volume":"192","author":"M Colaco","year":"2014","unstructured":"Colaco M, Koslov DS, Keys T, Evans RJ, Badlani GH, Andersson K-E, et al. Correlation of gene expression with bladder capacity in interstitial cystitis\/bladder pain syndrome. J Urol. 2014;192:1123\u20139. https:\/\/doi.org\/10.1016\/j.juro.2014.05.047.","journal-title":"J Urol"},{"key":"3688_CR15","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1200\/JCO.2009.25.0977","volume":"28","author":"J-S Lee","year":"2010","unstructured":"Lee J-S, Leem S-H, Lee S-Y, Kim S-C, Park E-S, Kim S-B, et al. Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. J Clin Oncol. 2010;28:2660\u20137. https:\/\/doi.org\/10.1200\/JCO.2009.25.0977.","journal-title":"J Clin Oncol"},{"key":"3688_CR16","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.asjsur.2022.07.080","volume":"46","author":"T-Y Cheng","year":"2023","unstructured":"Cheng T-Y, Tang T-Y, Hsu J-M, Lin T-F. Multifocal Xanthogranulomatous cystitis mimicking bladder malignancy: a case report and literature review. Asian J Surg. 2023;46:969\u201370. https:\/\/doi.org\/10.1016\/j.asjsur.2022.07.080.","journal-title":"Asian J Surg"},{"key":"3688_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12979-024-00432-5","volume":"21","author":"J Zhao","year":"2024","unstructured":"Zhao J, Luo X, Yang C, Yang X, Deng M, Sun B, et al. Chemokine receptor 7 contributes to T- and B-cell filtering in ageing bladder, cystitis and bladder cancer. Immun Ageing. 2024;21:33. https:\/\/doi.org\/10.1186\/s12979-024-00432-5.","journal-title":"Immun Ageing"},{"key":"3688_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s13287-025-04503-2","volume":"16","author":"PS Pezeshki","year":"2025","unstructured":"Pezeshki PS, Mahboubi A, Mohammadi Ganjaroudi N, Ghalehtaki R, Majidi Zolbin M, Salarvand S, et al. Human umbilical cord mesenchymal stem cells-derived extracellular vesicles as a therapeutic approach to ameliorate bladder injury in animal models of radiation cystitis. Stem Cell Res Ther. 2025;16:387. https:\/\/doi.org\/10.1186\/s13287-025-04503-2.","journal-title":"Stem Cell Res Ther"},{"key":"3688_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.22","volume":"3","author":"O Sanli","year":"2017","unstructured":"Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, et al. Bladder cancer. Nat Rev Dis Primers. 2017;3:17022. https:\/\/doi.org\/10.1038\/nrdp.2017.22.","journal-title":"Nat Rev Dis Primers"},{"key":"3688_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-1-0716-4276-4_8","volume":"2880","author":"F Wen","year":"2025","unstructured":"Wen F, Kumari N, Taylor Vi JG. RNA-seq and gene set enrichment analysis (GSEA) in peripheral blood mononuclear cells (PBMCs). Methods Mol Biol. 2025;2880:179\u201392. https:\/\/doi.org\/10.1007\/978-1-0716-4276-4_8.","journal-title":"Methods Mol Biol"},{"key":"3688_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-020-03910-x","volume":"21","author":"S Canzler","year":"2020","unstructured":"Canzler S, Hackerm\u00fcller J. multiGSEA: a GSEA-based pathway enrichment analysis for multi-omics data. BMC Bioinform. 2020;21:561. https:\/\/doi.org\/10.1186\/s12859-020-03910-x.","journal-title":"BMC Bioinform"},{"key":"3688_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02396-8","volume":"21","author":"HE Marei","year":"2021","unstructured":"Marei HE, Althani A, Afifi N, Hasan A, Caceci T, Pozzoli G, et al. p53 signaling in cancer progression and therapy. Cancer Cell Int. 2021;21:703. https:\/\/doi.org\/10.1186\/s12935-021-02396-8.","journal-title":"Cancer Cell Int"},{"key":"3688_CR23","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2025048","author":"T Chen","year":"2025","unstructured":"Chen T, Xu Y, Yang K, Du Y, Zhu Z, Xu L, et al. Withaferin A combined with ricolinostat: a potent synergistic therapy for cervical cancer through regulating p53 ubiquitination and acetylation. Acta Biochim Biophys Sin. 2025. https:\/\/doi.org\/10.3724\/abbs.2025048.","journal-title":"Acta Biochim Biophys Sin"},{"key":"3688_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/cdd.2009.77","volume":"17","author":"JT Lee","year":"2010","unstructured":"Lee JT, Gu W. The multiple levels of regulation by p53 ubiquitination. Cell Death Differ. 2010;17:86\u201392. https:\/\/doi.org\/10.1038\/cdd.2009.77.","journal-title":"Cell Death Differ"},{"key":"3688_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2025.103055","volume":"92","author":"Z Rizvi","year":"2025","unstructured":"Rizvi Z, Lander GC. Illuminating ubiquitination mechanisms: How cryo-EM has shed light on Cullin RING E3 ligase function. Curr Opin Struct Biol. 2025;92:103055. https:\/\/doi.org\/10.1016\/j.sbi.2025.103055.","journal-title":"Curr Opin Struct Biol"},{"key":"3688_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-020-00276-w","volume":"9","author":"L Shi","year":"2020","unstructured":"Shi L, Du D, Peng Y, Liu J, Long J. The functional analysis of Cullin 7 E3 ubiquitin ligases in cancer. Oncogenesis. 2020;9:98. https:\/\/doi.org\/10.1038\/s41389-020-00276-w.","journal-title":"Oncogenesis"},{"key":"3688_CR27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.4149\/neo_2021_201207N1324","volume":"68","author":"Y Li","year":"2021","unstructured":"Li Y, Zang A, Fu J, Jia Y. Cullin 7 in tumor development: a novel potential anti-cancer target. Neoplasma. 2021;68:572\u20139. https:\/\/doi.org\/10.4149\/neo_2021_201207N1324.","journal-title":"Neoplasma"},{"key":"3688_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1043512","volume":"13","author":"C Wang","year":"2022","unstructured":"Wang C, Zhao Z, Zhang Y, Liang W, Zhou C, Lin W, et al. Identification and verification of the prognostic value of CUL7 in colon adenocarcinoma. Front Immunol. 2022;13:1043512. https:\/\/doi.org\/10.3389\/fimmu.2022.1043512.","journal-title":"Front Immunol"},{"key":"3688_CR29","doi-asserted-by":"publisher","first-page":"F814","DOI":"10.1152\/ajprenal.00049.2024","volume":"326","author":"SK Murali","year":"2024","unstructured":"Murali SK, McCormick JA, Fenton RA. Regulation of the water channel aquaporin-2 by cullin E3 ubiquitin ligases. Am J Physiol Renal Physiol. 2024;326:F814\u201326. https:\/\/doi.org\/10.1152\/ajprenal.00049.2024.","journal-title":"Am J Physiol Renal Physiol"},{"key":"3688_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41420-025-02426-8","volume":"11","author":"Y Yang","year":"2025","unstructured":"Yang Y, Ma Y, Fan S, Zhu J, Ye B, Zhang R, et al. MLN4924 suppresses tumor metabolism and growth of clear cell renal cell carcinoma by stabilizing nuclear FBP1. Cell Death Discov. 2025;11:253. https:\/\/doi.org\/10.1038\/s41420-025-02426-8.","journal-title":"Cell Death Discov"},{"key":"3688_CR31","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41594-022-00815-6","volume":"29","author":"LVM Hopf","year":"2022","unstructured":"Hopf LVM, Baek K, Kl\u00fcgel M, von Gronau S, Xiong Y, Schulman BA. Structure of CRL7FBXW8 reveals coupling with CUL1-RBX1\/ROC1 for multi-cullin-RING E3-catalyzed ubiquitin ligation. Nat Struct Mol Biol. 2022;29:854\u201362. https:\/\/doi.org\/10.1038\/s41594-022-00815-6.","journal-title":"Nat Struct Mol Biol"},{"key":"3688_CR32","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.molcel.2014.03.047","volume":"54","author":"J Yan","year":"2014","unstructured":"Yan J, Yan F, Li Z, Sinnott B, Cappell KM, Yu Y, et al. The 3M complex maintains microtubule and genome integrity. Mol Cell. 2014;54:791\u2013804. https:\/\/doi.org\/10.1016\/j.molcel.2014.03.047.","journal-title":"Mol Cell"},{"key":"3688_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00431-024-05855-2","volume":"184","author":"A Akal\u0131n","year":"2024","unstructured":"Akal\u0131n A, \u00d6zalkak \u015e, Y\u0131ld\u0131r\u0131m R, Karakaya AA, Kolba\u015f\u0131 B, Durmu\u015falio\u011flu EA, et al. Clinical and molecular spectrum along with genotype-phenotype correlation of 25 patients diagnosed with 3 M syndrome: a study from Turkey. Eur J Pediatr. 2024;184:68. https:\/\/doi.org\/10.1007\/s00431-024-05855-2.","journal-title":"Eur J Pediatr"},{"key":"3688_CR34","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI129107","volume":"129","author":"P Wang","year":"2019","unstructured":"Wang P, Yan F, Li Z, Yu Y, Parnell SE, Xiong Y. Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development. J Clin Investig. 2019;129:4393\u2013407. https:\/\/doi.org\/10.1172\/JCI129107.","journal-title":"J Clin Investig"},{"key":"3688_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02704-6","volume":"42","author":"W Cao","year":"2025","unstructured":"Cao W, Tan X, Li X, Wang Y, Zhai Y, Zhang Z, et al. MIS18BP1 promotes bladder cancer cell proliferation and growth via inactivating P53 signaling pathway. Med Oncol. 2025;42:156. https:\/\/doi.org\/10.1007\/s12032-025-02704-6.","journal-title":"Med Oncol"},{"key":"3688_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11596-023-2814-6","volume":"44","author":"W-X An","year":"2024","unstructured":"An W-X, Gupta R, Zhai K, Wang Y-R, Xu W-H, Cui Y. Current and potential roles of ferroptosis in bladder cancer. Curr Med Sci. 2024;44:51\u201363. https:\/\/doi.org\/10.1007\/s11596-023-2814-6.","journal-title":"Curr Med Sci"},{"key":"3688_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adt0983","volume":"18","author":"J Levey","year":"2025","unstructured":"Levey J, Abedin M, Zhang C, Odame E, Zhang L, Jo H-N, et al. The MDM2-p53 axis regulates norrin\/frizzled4 signaling and blood-CNS barrier function. Sci Signal. 2025;18:eadt0983. https:\/\/doi.org\/10.1126\/scisignal.adt0983.","journal-title":"Sci Signal"},{"key":"3688_CR38","doi-asserted-by":"publisher","unstructured":"Xie C, Liang X-L, Chen B, Chen S, Xiong F-X, Wang Q-C, et al. hMTR4 promotes p53 protein degradation and tumor growth by accelerating rRNA processing and regulating the RPL5-MDM2 axis. Cell Death Differ. 2025. https:\/\/doi.org\/10.1038\/s41418-025-01541-4.","DOI":"10.1038\/s41418-025-01541-4"},{"key":"3688_CR39","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1053\/j.gastro.2019.10.040","volume":"158","author":"D Ray","year":"2020","unstructured":"Ray D, Ray P, Ferrer-Torres D, Wang Z, Nancarrow D, Yoon H-W, et al. Isoforms of RNF128 regulate the stability of mutant P53 in Barrett\u2019s esophageal cells. Gastroenterology. 2020;158:583\u201397.e1. https:\/\/doi.org\/10.1053\/j.gastro.2019.10.040.","journal-title":"Gastroenterology"},{"key":"3688_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1977-3","volume":"10","author":"Y Chen","year":"2019","unstructured":"Chen Y, Hao Q, Wang J, Li J, Huang C, Zhang Y, et al. Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53. Cell Death Dis. 2019;10:737. https:\/\/doi.org\/10.1038\/s41419-019-1977-3.","journal-title":"Cell Death Dis"},{"key":"3688_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40617-y","volume":"14","author":"Y Enomoto","year":"2023","unstructured":"Enomoto Y, Katsura H, Fujimura T, Ogata A, Baba S, Yamaoka A, et al. Autocrine TGF-\u03b2-positive feedback in profibrotic AT2-lineage cells plays a crucial role in non-inflammatory lung fibrogenesis. Nat Commun. 2023;14:4956. https:\/\/doi.org\/10.1038\/s41467-023-40617-y.","journal-title":"Nat Commun"},{"key":"3688_CR42","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.21037\/tau-2025-183","volume":"14","author":"SJ Ivan","year":"2025","unstructured":"Ivan SJ, Lee M, Simhan J. Contemporary management of radiation-associated posterior urethral stenosis: a narrative review. Transl Androl Urol. 2025;14:3377\u201386. https:\/\/doi.org\/10.21037\/tau-2025-183.","journal-title":"Transl Androl Urol"},{"key":"3688_CR43","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.21037\/tau-2025-483","volume":"14","author":"A Albakr","year":"2025","unstructured":"Albakr A, Narayan VM, Tyson M, Shoskes D, Vasavada S. Pharmacotherapy for bladder spasm and irritative lower urinary tract symptoms associated with intravesical therapy for bladder cancer: a review of available evidence. Transl Androl Urol. 2025;14:3402\u201312. https:\/\/doi.org\/10.21037\/tau-2025-483.","journal-title":"Transl Androl Urol"},{"key":"3688_CR44","doi-asserted-by":"publisher","first-page":"e21200042","DOI":"10.14440\/bladder.2024.0054","volume":"12","author":"C Mahapatra","year":"2025","unstructured":"Mahapatra C. Artificial intelligence for diagnosing bladder pathophysiology: An updated review and future prospects. Bladder. 2025;12:e21200042. https:\/\/doi.org\/10.14440\/bladder.2024.0054.","journal-title":"Bladder"},{"key":"3688_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.canlet.2019.08.008","volume":"464","author":"N Qiu","year":"2019","unstructured":"Qiu N, He Y-F, Zhang S-M, Zhan Y-T, Han G-D, Jiang M, et al. Cullin7 enhances resistance to trastuzumab therapy in Her2 positive breast cancer via degrading IRS-1 and downregulating IGFBP-3 to activate the PI3K\/AKT pathway. Cancer Lett. 2019;464:25\u201336. https:\/\/doi.org\/10.1016\/j.canlet.2019.08.008.","journal-title":"Cancer Lett"},{"key":"3688_CR46","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3892\/ijmm.2018.3359","volume":"41","author":"J Zhi","year":"2018","unstructured":"Zhi J, Sun J, Wang Z, Ding W. Support vector machine classifier for prediction of the metastasis of colorectal cancer. Int J Mol Med. 2018;41:1419\u201326. https:\/\/doi.org\/10.3892\/ijmm.2018.3359.","journal-title":"Int J Mol Med"},{"key":"3688_CR47","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.humpath.2017.07.008","volume":"67","author":"J An","year":"2017","unstructured":"An J, Liu Z, Liang Q, Pan Y, Li H, Wang R, et al. Overexpression of Rabl3 and Cullin7 is associated with pathogenesis and poor prognosis in hepatocellular carcinoma. Hum Pathol. 2017;67:146\u201351. https:\/\/doi.org\/10.1016\/j.humpath.2017.07.008.","journal-title":"Hum Pathol"},{"key":"3688_CR48","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/cells14080583","volume":"14","author":"Y Huang","year":"2025","unstructured":"Huang Y, Li W, Zhou Y, Bai J, Li N, Su Z, et al. Strategies for p53 activation and targeted inhibitors of the p53-Mdm2\/MdmX interaction. Cells. 2025;14:583 https:\/\/doi.org\/10.3390\/cells14080583.","journal-title":"Cells"},{"key":"3688_CR49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.22099\/mbrc.2025.51477.2054","volume":"14","author":"R Mirgayazova","year":"2025","unstructured":"Mirgayazova R, Khadiullina R, Gilyazova E, Davletshin D, Ganeeva I, Zmievskaya E, et al. The importance of TP53 status in cancer therapy: The example of chronic lymphocytic leukemia. Mol Biol Res Commun. 2025;14:179\u201398. https:\/\/doi.org\/10.22099\/mbrc.2025.51477.2054.","journal-title":"Mol Biol Res Commun"},{"key":"3688_CR50","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.7150\/thno.78876","volume":"13","author":"Z-X He","year":"2023","unstructured":"He Z-X, Yang W-G, Zengyangzong D, Gao G, Zhang Q, Liu H-M, et al. Targeting cullin neddylation for cancer and fibrotic diseases. Theranostics. 2023;13:5017\u201356. https:\/\/doi.org\/10.7150\/thno.78876.","journal-title":"Theranostics"},{"key":"3688_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39537-0","volume":"13","author":"D Zhu","year":"2023","unstructured":"Zhu D, Qi H, Zhu H. hsa-miR-199b-3p suppresses osteosarcoma progression by targeting CCDC88A, inhibiting epithelial-to-mesenchymal transition, and Wnt\/beta-catenin signaling pathway. Sci Rep. 2023;13:12544. https:\/\/doi.org\/10.1038\/s41598-023-39537-0.","journal-title":"Sci Rep"},{"key":"3688_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12451-y","volume":"24","author":"M Yu","year":"2024","unstructured":"Yu M, Peng J, Lu Y, Li S, Ding K. Silencing immune-infiltrating biomarker CCDC80 inhibits malignant characterization and tumor formation in gastric cancer. BMC Cancer. 2024;24:724. https:\/\/doi.org\/10.1186\/s12885-024-12451-y.","journal-title":"BMC Cancer"},{"key":"3688_CR53","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.7150\/jca.97640","volume":"15","author":"X Li","year":"2024","unstructured":"Li X, Du Y. Lactate metabolism subtypes analysis reveals CCDC80 as a novel prognostic biomarker in gastric cancer. J Cancer. 2024;15:5557\u201376. https:\/\/doi.org\/10.7150\/jca.97640.","journal-title":"J Cancer"},{"key":"3688_CR54","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s12276-022-00735-x","volume":"54","author":"N Zhang","year":"2022","unstructured":"Zhang N, Shen Y, Li H, Chen Y, Zhang P, Lou S, et al. The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability. Exp Mol Med. 2022;54:194\u2013205. https:\/\/doi.org\/10.1038\/s12276-022-00735-x.","journal-title":"Exp Mol Med"},{"key":"3688_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-025-00870-z","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Mena EL, Timms RT, Koren I, Elledge SJ. Degrons: defining the rules of protein degradation. Nat Rev Mol Cell Biol. 2025. https:\/\/doi.org\/10.1038\/s41580-025-00870-z.","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03688-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03688-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03688-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T23:03:58Z","timestamp":1771283038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03688-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,3,10]]}},"alternative-id":["3688"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03688-x","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The use of human specimens in this study was approved by the Ethics Committee of Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences (Approval No. 2020BJYYEC-141-01). Written informed consent was obtained from all participants prior to sample collection. All animal experiments were conducted in accordance with institutional ethical guidelines and were approved by the Institutional Animal Care and Use Committee of Shengli Clinical Medical College, Fujian Medical University, Fujian Provincial Hospital (Approval No. IACUC-FPH-SL-20250210). According to the approved animal protocol, the maximal allowable tumor volume was 1500\u2009mm\u00b3. Throughout the entire study, tumor sizes in all animals remained below this threshold. All procedures were performed in compliance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}